期 |
栏目 |
标题 |
文件 |
卷 8, 编号 9 (2022) |
Articles |
Peculiarities of the course of rheumatoid arthritis in patients with thrombocytosis |
|
编号 5 (2017) |
Articles |
Matvey Yakovlevich Mudrov (1776-1831) and Saint-Petersburg clinical medicine |
|
编号 4 (2018) |
Articles |
Uveites as paradoxal reaction or nonefficacy of treatment in ankylosing spondylitis patients, getting inhibitors of alpha tumour necrosis factor |
|
编号 7-8 (2018) |
Articles |
New possibilities of uratedecreasing therapy in patients with arthrolithiasis |
|
卷 7, 编号 4 (2021) |
Articles |
Combined drug therapy of post-traumatic osteoarthritis: data from a three-year prospective study |
|
卷 7, 编号 10 (2021) |
Articles |
Features of the clinical course of rheumatic diseases in patients who have had a new coronavirus infection |
|
卷 7, 编号 10 (2021) |
Articles |
Dynamics of hemostasis system and c-reactive protein indexes while new oral anticoagulants intake in patients after hip joint endoprosthesis replacement |
|
卷 7, 编号 10 (2021) |
Articles |
Effect of platelets on the course of rheumatoid arthritis and cardiovascular risk |
|
卷 7, 编号 10 (2021) |
Articles |
Modern principles of osteoporosis therapy |
|
卷 7, 编号 10 (2021) |
Articles |
Atypical celiac disease with late onset, damage of gastrointestinal tract, nervous and musculoskeletal systems of the organism |
|
卷 8, 编号 2 (2022) |
Articles |
MULTICENTER PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF THE COMBINED USE OF GLYCOSAMINOGLYCAN-PEPTIDE COMPLEX AND DIACEREIN IN PATIENTS WITH KNEE OSTEOARTHRITIS |
|
卷 8, 编号 2 (2022) |
Articles |
«INCOMPLETE» SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL CLINICAL PRACTICE: DIFFICULTIES OF DIAGNOSIS |
|
卷 8, 编号 6 (2022) |
Articles |
The effect of asymptomatic hyperuricemia on the frequency and structure of comorbidity patients with rheumatoid arthritis |
|
卷 9, 编号 1 (2023) |
ORIGINAL STUDIES |
Peculiarities of the course of rheumatoid arthritis in patients with thrombocytosis and comorbid conditions |
|
卷 9, 编号 1 (2023) |
ORIGINAL STUDIES |
Influence of comorbid pathology at the course of spondyloarthritis in patients receiving genetically engineered biological therapy |
|
卷 9, 编号 1 (2023) |
ORIGINAL STUDIES |
Comparative analysis of efficacy and safety of different medicines containing celecoxib in patients with knee osteoarthritis |
|
卷 9, 编号 1 (2023) |
REVIEWS |
Treatment of giant cell arteritis: current possibilities and prospects of steroid-sparing therapy |
|
卷 9, 编号 1 (2023) |
HELPING PRACTICING PHYSICIAN |
Still’s disease in adults: methodological recommendations for general practitioners, therapists |
|
卷 9, 编号 1 (2023) |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
Therapy of osteoarthritis in combination with assymptomatic hyperuricemia: results of a pilot study |
|
卷 9, 编号 1 (2023) |
ACTIVITIES OF RSMSIM |
Congress of therapists of the Northwestern Federal District «Dialogues on internal medicine» |
|
卷 9, 编号 3 (2023) |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
Increasing of glomeral filtration rate in the setting of serum uric acid normalization in high cardiovascular risk patients – clinical observations |
|
卷 9, 编号 7 (2023) |
ORIGINAL STUDIES |
Effect of urate-lowering therapy on the progression of chronic kidney disease in patients with osteoarthritis and asymptomatic hyperuricemia |
|
卷 9, 编号 10 (2023) |
ORIGINAL STUDIES |
Meta-analysis of observational cohort studies on the relationships of asymptomatic hyperuricemia with chronic kidney disease |
|